drugset / Trial / NCT05784363

A Study of NT 201 in the Treatment of Enlarged Pores and Excessive Sebum Production in the Face

NCT05784363

Phase 1 Completed 31 enrolled Merz North America, Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to investigate the efficacy and safety of NT 201 injections in the treatment of enlarged pores and excessive sebum production in the face.

Timeline

Start
2022-10-27
Primary completion
2024-06-17
Completion
2024-07-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic

Indications

No indication recorded.